|
1
|
Ramesh C, Vinithkumar NV, Kirubagaran R,
Venil CK and Dufossé L: Multifaceted applications of microbial
pigments: Current knowledge, challenges and future directions for
public health implications. Microorganisms. 7:1862019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Choi SY, Lim S, Cho G, Kwon J, Mun W, Im H
and Mitchell RJ: Chromobacterium violaceum delivers
violacein, a hydrophobic antibiotic, to other microbes in membrane
vesicles. Environ Microbiol. 22:705–713. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Durán N, Justo GZ, Durán M, Brocchi M,
Cordi L, Tasic L, Castro GR and Nakazato G: Advances in
Chromobacterium violaceum and properties of violacein-Its
main secondary metabolite: A review. Biotechnol Adv. 34:1030–1045.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Choi SY, Yoon K, Lee JI and Mitchell RJ:
Violacein: Properties and production of a versatile bacterial
pigment. Biomed Res Int. 2015:4650562015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pantanella F, Berlutti F, Passariello C,
Sarli S, Morea C and Schippa S: Violacein and biofilm production in
Janthinobacterium lividum. J Appl Microbiol. 102:992–999.
2007.PubMed/NCBI
|
|
6
|
Cazoto LL, Martins D, Ribeiro MG, Durán N
and Nakazato G: Antibacterial activity of violacein against
Staphylococcus aureus isolated from bovine mastitis. J
Antibiot (Tokyo). 64:395–397. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sasidharan A, Sasidharan NK, Amma DB, Vasu
RK, Nataraja AV and Bhaskaran K: Antifungal activity of violacein
purified from a novel strain of Chromobacterium sp. NIIST
(MTCC 5522). J Microbiol. 53:694–701. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bilsland E, Tavella TA, Krogh R, Stokes
JE, Roberts A, Ajioka J, Spring DR, Andricopulo AD, Costa FT and
Oliver SG: Antiplasmodial and trypanocidal activity of violacein
and deoxyviolacein produced from synthetic operons. BMC Biotechnol.
18:222018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rodrigues AL, Trachtmann N, Becker J,
Lohanatha AF, Blotenberg J, Bolten CJ, Korneli C, de Souza Lima AO,
Porto LM, Sprenger GA and Wittmann C: Systems metabolic engineering
of Escherichia coli for production of the antitumor drugs violacein
and deoxyviolacein. Metab Eng. 20:29–41. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hashimi SM, Xu T and Wei MQ: Violacein
anticancer activity is enhanced under hypoxia. Oncol Rep.
33:1731–1736. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ferreira CV, Bos CL, Versteeg HH, Justo
GZ, Durán N and Peppelenbosch MP: Molecular mechanism of
violacein-mediated human leukemia cell death. Blood. 104:1459–1464.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zeiss CJ: The apoptosis-necrosis
continuum: Insights from genetically altered mice. Vet Pathol.
40:481–495. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kerr JF, Winterford CM and Harmon BV:
Apoptosis. Its significance in cancer and cancer therapy. Cancer.
73:2013–2026. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
de Carvalho DD, Costa FTM, Duran N and
Haun M: Cytotoxic activity of violacein in human colon cancer
cells. Toxicol In Vitro. 20:1514–1521. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alshatwi AA, Subash-Babu P and Antonisamy
P: Violacein induces apoptosis in human breast cancer cells through
up regulation of BAX, p53 and down regulation of MDM2. Exp Toxicol
Pathol. 68:89–97. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Masuelli L, Pantanella F, La Regina G,
Benvenuto M, Fantini M, Mattera R, Stefano ED, Mattei M, Silvestri
R, Schippa S, et al: Violacein, an indole-derived purple-colored
natural pigment produced by Janthinobacterium lividum,
inhibits the growth of head and neck carcinoma cell lines both in
vitro and in vivo. Tumour Biol. 37:3705–3717. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kodach LL, Bos CL, Durán N, Peppelenbosch
MP, Ferreira CV and Hardwick JCH: Violacein synergistically
increases 5-fluorouracil cytotoxicity, induces apoptosis and
inhibits Akt-mediated signal transduction in human colorectal
cancer cells. Carcinogenesis. 27:508–516. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
de Sousa Leal AM, de Queiroz JDF, de
Medeiros SRB, de Souza Lima TK and Agnez-Lima LF: Violacein induces
cell death by triggering mitochondrial membrane hyperpolarization
in vitro. BMC Microbiol. 15:1152015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
American Cancer Society: Key Statistics
for Bladder Cancer. https://www.cancer.org/cancer/bladder-cancer/about/key-statistics.htmlNovember
10–2021PubMed/NCBI
|
|
21
|
Professionals S-O: EAU Guidelines:
Non-muscle-invasive Bladder Cancer. Uroweb. https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/November
10–2021
|
|
22
|
Burger M, Catto JWF, Dalbagni G, Grossman
HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, Vecchia CL,
Shariat S and Lotan Y: Epidemiology and risk factors of urothelial
bladder cancer. Eur Urol. 63:234–241. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
DeGeorge KC, Holt HR and Hodges SC:
Bladder cancer: Diagnosis and treatment. Am Fam Physician.
96:507–514. 2017.PubMed/NCBI
|
|
24
|
Kumar P, Nagarajan A and Uchil PD:
Analysis of cell viability by the MTT assay. Cold Spring Harb
Protoc. Jun 1–2018.doi: 10.1101/pdb.prot095505, 2018. View Article : Google Scholar
|
|
25
|
Davis JD: The evolution of the
progressive-era hemocytometer. Caduceus. 11:164–183.
1995.PubMed/NCBI
|
|
26
|
Porter AG and Jänicke RU: Emerging roles
of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bromberg N, Dreyfuss JL, Regatieri CV,
Palladino MV, Durán N, Nader HB, Haun M and Justo GZ: Growth
inhibition and pro-apoptotic activity of violacein in Ehrlich
ascites tumor. Chem Biol Interact. 186:43–52. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cohen GM: Caspases: The executioners of
apoptosis. Biochem J. 326:1–16. 1997. View Article : Google Scholar : PubMed/NCBI
|
